P3 Health Partners Inc. (PIII) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated April 4, 2025, discloses a corporate action regarding P3 Health Partners Inc. The report details the approval and implementation of a reverse stock split following a Special Meeting of Stockholders held on March 31, 2025.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the structural change to the company's capitalization.
Material Changes
- Reverse Stock Split Approval: The Board of Directors approved a 1-for-50 reverse stock split of all outstanding Class A and Class V common stock on April 1, 2025.
- Effective Date: The split is expected to become effective at 5:00 p.m. Eastern Time on April 11, 2025.
- Trading Resumption: Class A common stock is expected to commence trading on a split-adjusted basis on April 14, 2025, under the existing ticker symbol "PIII."
- New CUSIP: The new CUSIP number for the Class A common stock will be 744413 204.
- Warrants: Public warrants (PIIIW) will continue to trade with the same CUSIP number, though adjustments will be made to the number of shares underlying them and the exercise price.
- Fractional Shares: No fractional shares will be issued. Stockholders will receive a cash payment for fractional entitlements based on the closing price on the Effective Date.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the effective date of the split and the resumption of trading. Management notes these are based on current assumptions and involve risks that could cause actual results to differ. The filing directs investors to the "Risk Factors" section of the Annual Report on Form 10-K for the fiscal year ended December 31, 2024, for a comprehensive list of uncertainties.
Key Facts for Investor Verification
- Verify the final trading price of PIII on April 11, 2025, to calculate cash payments for fractional shares.
- Confirm the new CUSIP number (744413 204) with your brokerage to ensure proper account updates.
- Monitor the resumption of trading on April 14, 2025, under the existing ticker symbol.
- Review the adjusted exercise price and share count for any outstanding warrants or equity awards held.